Milestone Pharmaceuticals Inc. (MIST) Misses Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street mixed as oil prices surge, investors await earnings, economic data
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts MIST Hot Sheet
Join SI Premium – FREE
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q1 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20).
For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zuckerberg: Meta has reached AI ‘frontier,’ rejects calls for slowdown
- Active options: NVDA TSLA META AAPL MU SPCX INTC AMZN MSFT
- Bumble In Advanced Talks To Go Private At $1B Valuation - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
